Success rates with nicotine personal vaporizers: A prospective 6-month pilot study of smokers not intending to quit

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Polosa, Riccardo ^a,b   Caponnetto, Pasquale ^a,b   Maglia, Marilena ^a,b   Morjaria, Jaymin B ^c   Russo, Cristina ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Efficacy; Electronic cigarette; Personal vaporizers; Safety; Smoking cessation; Smoking reduction; Tobacco harm reduction

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; FEMALE; HEALTH BEHAVIOR; HUMAN; MALE; MIDDLE AGED; PILOT STUDY; PROCEDURES; PROSPECTIVE STUDY; SMOKING CESSATION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ELECTRONIC CIGARETTES; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; NICOTINE; PILOT PROJECTS; PROSPECTIVE STUDIES; SMOKING CESSATION;

EID: 84924719277     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-1159     Document Type: Article

References (36)

1. Buchhalter AR, Acosta MC, Evans SE, Breland AB, Eissenberg T: Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction 2005, 100(4):550-559.
2. Hughes JR, Keely J, Naud S: Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004, 99(1):29-38.
3. Polosa R, Benowitz NL: Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 2011, 32(5):281-289.
4. Stead LF, Lancaster T: Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2012, 10:CD008286.
5. Apelberg BJ, Onicescu G, Avila-Tang E, Samet JM: Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States. Am J Public Health 2010, 100(2):341-348.
6. Casella G, Caponnetto P, Polosa R: Therapeutic advances in the treatment of nicotine addiction: present and future. Ther Adv Chronic Dis 2010, 1(3):95-106.
7. Alpert HR, Connolly GN, Biener L: A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control 2013, 22(1):32-37.
8. Pierce JP, Cummins SE, White MM, Humphrey A, Messer K: Quitlines and nicotine replacement for smoking cessation: do we need to change policy? Annu Rev Public Health 2012, 33:341-356.
9. Zhu SH, Lee M, Zhuang YL, Gamst A, Wolfson T: Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tob Control 2012, 21(2):110-118.
10. Caponnetto P, Campagna D, Papale G, Russo C, Polosa R: The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med 2012, 6(1):63-74.
11. Caponnetto P, Russo C, Bruno CM, Alamo A, Amaradio MD, Polosa R: Electronic cigarette: a possible substitute for cigarette dependence. Monaldi Arch Chest Dis 2013, 79(1):12-19.
12. Dawkins L, Turner J, Roberts A, Soar K: 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 2013, 108(6):1115-1125.
13. Etter JF, Bullen C: Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011, 106(11):2017-2028.
14. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R: EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013, 8(6):e66317.
15. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N: Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013, 382(9905):1629-1637.
16. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L: Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013, 15(1):158-166.
17. Dawkins L, Corcoran O: Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) 2014, 231(2):401-407.
18. Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V: Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep 2014, 4:4133.
19. Fagerstrom KO, Schneider NG: Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989, 12(2):159-182.
20. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J: Manual for the Beck Depression Inventory. New York: Harcourt Brace Jovanovich; 1987.
21. Bolliger CT, Zellweger JP, Danielsson T, van Biljon X, Robidou A, Westin A, Perruchoud AP, Sawe U: Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000, 321(7257):329-333.
22. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C: Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011, 11:786.
23. Smith SS, McCarthy DE, Japuntich SJ, Christiansen B, Piper ME, Jorenby DE, Fraser DL, Fiore MC, Baker TB, Jackson TC: Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med 2009, 169(22):2148-2155.
24. Polosa R, Caponnetto P: Advances in Smoking Cessation. London: Future Medicine, Ltd; 2013.
25. Wieslander G, Norback D, Lindgren T: Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001, 58(10):649-655.
26. Varughese S, Teschke K, Brauer M, Chow Y, van Netten C, Kennedy SM: Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am J Ind Med 2005, 47(5):411-418.
27. Fagerstrom KO, Hughes JR, Rasmussen T, Callas PW: Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit. Tob Control 2000, 9(3):327-333.
28. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M: Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010, 19(2):98-103.
29. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D: Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach. Eur Addict Res 2014, 20(5):218-225.
30. Farsalinos KE, Polosa R: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarettes substitutes: A systematic review. Ther Adv Drug Saf 2014, 5:67-86.
31. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V: Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse 2013, 7:139-146.
32. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V: Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Environ Res Public Health 2013, 10(12):7272-7282.
33. Polosa R, Rodu B, Caponnetto P, Maglia M, Raciti C: A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 2013, 10(1):19.
34. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R: Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 2013, 10(2):446-461.
35. Polosa R, Morjaria JB, Caponnetto P, Caruso M, Strano S, Battaglia E, Russo C: Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal (in press). Int J Environ Res Public Health 2014, 11(5):4965-4977.
36. Saitta D, Ferro GA, Polosa R: Achieving appropriate regulations for electronic cigarettes. Ther Adv Chronic Dis 2014, 5(2):50-61.